Novel Monoclonal Antibody Developed to Treat Yellow Fever
Singapore-based clinical-stage biotechnology company, Tychan announces results for Phase 1 Trial for TY014, a novel monoclonal antibody candidate treatment for yellow fever. Results of Phase 1 trial...